{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06232577",
            "orgStudyIdInfo": {
                "id": "2023-0818"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2024-00632",
                    "type": "OTHER",
                    "domain": "NCI-CTRP Clinical Registry"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial",
            "officialTitle": "5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "multiplier-vs-tier-model-for-discharge-opioid-prescriptions-after-intra-abdominal-cancer-surgery-a-randomized-clinical-trial"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-27",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-07-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-22",
            "studyFirstSubmitQcDate": "2024-01-22",
            "studyFirstPostDateStruct": {
                "date": "2024-01-31",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "To compare 2 different models for prescribing opioid pain medication to provide better pain control to participants with an abdominal cancer who are having surgery.",
            "detailedDescription": "Primary Objectives:\n\nThe co-primary objectives of this study are as follows:\n\n1. To determine differences in the initial OME prescribed upon discharge between each algorithm/model.\n\n1. To determine OME usage by day 14 after hospital discharge.\n\nSecondary Objectives:\n\nSecondary objectives are as follows:\n\n1. To determine rates of patients with zero OME upon discharge.\n2. To determine rates of OME refill requests and completions at 15- and 30-days post-operation.\n3. To determine number of unused or leftover pills at 15- and 30-days post- operation\n4. To determine persistent opioid use at 30-days, 3-months, and 6-months post-operation\n5. To elucidate patient, prescriber, and oncologic factors predictive of persistent opioid use\n6. To assess quality of life using patient-reported outcomes at 30-days, 3-months, and 6-months post-operation.\n7. To determine patient satisfaction with either prescribing model."
        },
        "conditionsModule": {
            "conditions": [
                "Intra-abdominal Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "5x-Multiplier Model",
                    "type": "EXPERIMENTAL",
                    "description": "In this group, you will be given 5 times the amount of opioid medication you needed on your last day in the hospital. You would then use this supply plus standard non-narcotic pain medications.",
                    "interventionNames": [
                        "Drug: Hydrocodone",
                        "Drug: Tramadol",
                        "Drug: Oxycodone"
                    ]
                },
                {
                    "label": "3-Tier Model",
                    "type": "EXPERIMENTAL",
                    "description": "The total amount of opioid medication you needed on your last day in the hospital to set a maximum number of opioid medications at discharge (up to 30).",
                    "interventionNames": [
                        "Drug: Hydrocodone",
                        "Drug: Tramadol",
                        "Drug: Oxycodone"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Hydrocodone",
                    "description": "Given by PO",
                    "armGroupLabels": [
                        "3-Tier Model",
                        "5x-Multiplier Model"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Tramadol",
                    "description": "Given by PO",
                    "armGroupLabels": [
                        "3-Tier Model",
                        "5x-Multiplier Model"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Oxycodone",
                    "description": "Given by PO",
                    "armGroupLabels": [
                        "3-Tier Model",
                        "5x-Multiplier Model"
                    ],
                    "otherNames": [
                        "ETH-Oxydose\u2122 [DSC]",
                        "OxyContin\u00ae",
                        "OxyIR\u00ae",
                        "Roxicodone\u00ae"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety and adverse events (AEs)",
                    "description": "Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0",
                    "timeFrame": "Through study completion; an average of 1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants \u226518 years of age\n* Participants undergoing any of the following abdominal surgeries on an elective basis at MD Anderson Cancer Center:\n* Open pancreatectomy\n* Open hepatectomy\n* Open resection of retroperitoneal sarcoma\n* Open nephrectomy\n* Open cytoreductive surgery (in ovarian cancer)\n* Participants with a planned inpatient admission of at least 48 hours after surgery\n* Opioid-naive patients who use less than or equal to 7.5 mg OME per day (on average) during the 30 days prior to consent\n* Participants able to understand and willing to sign an informed consent document\n* English and non-English-speaking participants\n\nExclusion Criteria:\n\n* Participants requiring non-elective (emergent or urgent) surgery will be excluded\n* Participants with a current or previous history of substance abuse disorder, including alcohol or drugs\n* Participants prescribed long-acting chronic pain medications\n* Participants using hydromorphone or fentanyl or under the care of a chronic pain specialist\n* Participants unable or unwilling to participate in follow-up study requirements (e.g., QOL surveys, opioid log)\n* Participants discharged on palliative or hospice care\n* Participants with a history of allergic reactions to opioids\n* Participants enrolled in any other opioid discharge protocol\n* Participants who are pregnant\n* Participants who are cognitively impaired",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ching-Wei D Tzeng, MD",
                    "role": "CONTACT",
                    "phone": "(713) 792-0386",
                    "email": "cdtzeng@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ching-Wei D Tzeng, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ching-Wei D Tzeng, MD",
                            "role": "CONTACT",
                            "phone": "713-792-0386",
                            "email": "cdtzeng@mdanderson.org"
                        },
                        {
                            "name": "Ching-Wei D Tzeng, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "MD Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000008",
                    "term": "Abdominal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7",
                    "name": "Abdominal Neoplasms",
                    "asFound": "Abdominal Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010098",
                    "term": "Oxycodone"
                },
                {
                    "id": "D000014147",
                    "term": "Tramadol"
                },
                {
                    "id": "D000006853",
                    "term": "Hydrocodone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000701",
                    "term": "Analgesics, Opioid"
                },
                {
                    "id": "D000009294",
                    "term": "Narcotics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000000996",
                    "term": "Antitussive Agents"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                },
                {
                    "id": "M13020",
                    "name": "Oxycodone",
                    "asFound": "Where",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M9911",
                    "name": "Hydrocodone",
                    "asFound": "Neurocognitive",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16901",
                    "name": "Tramadol",
                    "asFound": "Cognitive Behavioral Therapy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12245",
                    "name": "Narcotics",
                    "relevance": "LOW"
                },
                {
                    "id": "M13570",
                    "name": "Phenylpropanolamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M9238",
                    "name": "Guaifenesin",
                    "relevance": "LOW"
                },
                {
                    "id": "M186319",
                    "name": "Chlorpheniramine, phenylpropanolamine drug combination",
                    "relevance": "LOW"
                },
                {
                    "id": "M4312",
                    "name": "Antitussive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnTuAg",
                    "name": "Antitussive Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "AnObAg",
                    "name": "Anti-Obesity Agents"
                },
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                }
            ]
        }
    },
    "hasResults": false
}